C07K 14/70596
Molecules with a "cd"-designation not provided for elsewhere
Official title: {Molecules with a "CD"-designation not provided for elsewhere}
C07K14/70596 (Molecules with a "cd"-designation not provided for elsewhere) appears on 1,186 US grants and 2,167 published applications in this corpus.
Search patents in C07K- Granted patents
- 1,186
- Published applications
- 2,167
- Assignees
- 995
- Inventors
- 4,167
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 2 | 0 |
| 1993 | 7 | 0 |
| 1994 | 6 | 0 |
| 1995 | 3 | 0 |
| 1996 | 10 | 0 |
| 1997 | 10 | 0 |
| 1998 | 23 | 0 |
| 1999 | 23 | 0 |
| 2000 | 16 | 0 |
| 2001 | 22 | 5 |
| 2002 | 20 | 42 |
| 2003 | 20 | 50 |
| 2004 | 20 | 41 |
| 2005 | 19 | 46 |
| 2006 | 17 | 39 |
| 2007 | 17 | 20 |
| 2008 | 25 | 27 |
| 2009 | 17 | 27 |
| 2010 | 23 | 43 |
| 2011 | 21 | 36 |
| 2012 | 24 | 28 |
| 2013 | 26 | 40 |
| 2014 | 26 | 51 |
| 2015 | 28 | 63 |
| 2016 | 33 | 71 |
| 2017 | 45 | 65 |
| 2018 | 47 | 106 |
| 2019 | 50 | 127 |
| 2020 | 66 | 157 |
| 2021 | 79 | 179 |
| 2022 | 103 | 215 |
| 2023 | 75 | 192 |
| 2024 | 90 | 207 |
| 2025 | 107 | 167 |
| 2026 | 66 | 123 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions, methods and kits for treating complement related disorders6 Oct 2026US 12,751,993 B2Trustees of Tufts College
- Combined chimeric antigen receptor targeting CD19 and CD20 and application thereof6 Oct 2026US 12,753,221 B2Abelzeta Inc.
- Fusion protein comprising anti-CD3 single domain antibody, exosomal protein CD63 and RNA binding protein, and uses thereof6 Oct 2026US 12,753,232 B1China Medical University Hospital
- Chimeric antigen receptor for treatment of cancer29 Sep 2026US 12,747,278 B2Industry-Academic Cooperation Foundation, Yonsei University
- Chimeric antigen receptors with CD20 safety switch22 Sep 2026US 12,742,001 B2St. Jude Children?S Research Hospital
- Chimeric engulfment receptor molecules and methods of use8 Oct 2026US 2026/0308281 A1Cero Therapeutics Holdings, Inc.
- Modulation of the btla-hvem axis to enhance adoptive cell transfer immunotherapy8 Oct 2026US 2026/0308519 A1The Trustees of the University of Pennsylvania
- Rapid selection system for the generation of recombinant enveloped viruses8 Oct 2026US 2026/0308627 A1Probiogen AG
- Anti-fibrotic peptides and uses thereof1 Oct 2026US 2026/0297164 A1Deackt, Inc.
- Compositions and methods for expressing therapeutics1 Oct 2026US 2026/0297165 A1Avirmax Biopharma Inc.
Most cited
By later US patents
- Methods for treatment of cancer368US 8,906,682 B2The Trustees of the University of Pennsylvania · 2014
- Compositions for treatment of cancer277US 8,911,993 B2The Trustees of the University of Pennsylvania · 2014
- Methods for treatment of cancer216US 8,916,381 B1The Trustees of the University of Pennyslvania · 2014
- Compositions for treatment of cancer199US 8,975,071 B1The Trustees of the University of Pennsylvania · 2015
- Methods for treatment of cancer199US 9,101,584 B2The Trustees of the University of Pennsylvania · 2015